Back to Search
HEATHER SCHMIDT, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1922398452Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
PMID 17443000·J Clin Oncol·2007
3-trial
Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.
PMID 17141806·J Mol Biol·2007
8-other
Systemic administration of a dopamine, but not a serotonin or norepinephrine, transporter inhibitor reinstates cocaine seeking in the rat.
PMID 16978714·Behav Brain Res·2006
4-observational
Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanoma.
PMID 16410782·J Invest Dermatol·2006
8-other
Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma.
PMID 16456816·Cancer·2006
8-other
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma.
PMID 16391295·J Clin Oncol·2006
8-other
Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.
PMID 16179868·Melanoma Res·2005
8-other
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.
PMID 16052222·Br J Cancer·2005
8-other
S100beta protein in peripheral blood may predict progressive disease during interleukin-2 based immunotherapy in patients with metastatic melanoma.
PMID 15179191·Melanoma Res·2004
3-trial
Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.
PMID 12459648·Melanoma Res·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 7575 GRAND RIVER RD, SUITE 209
BRIGHTON, MI 48114 - Phone
- (810) 844-7950
Quick Facts
- NPI
- 1922398452
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile